Home Search

respiratorius - search results

If you're not happy with the results, please do another search
Respiratorius CEO looks back at 2022

Respiratorius’ CEO comments on an eventful year

The value of patent protection in life science

The value of patent protection in life science

Watch BioStock Life Science Fall Summit!

Respiratorius pricing analysis

Pricing in focus for Respiratorius ahead of partnering discussions

Respiratorius closer to a deal

Respiratorius marches towards partnering deal

Touch start on the stock market for Arcede Pharma

Arcede Pharma share under pressure despite development progress

Arcede Pharma releases its first quarterly report

Arcede Pharma reports on the first quarter

ArcedePharma_MiaLundblad_BioStockInvestorMeeting

BioStock Investor Meeting: Arcede Pharma presents

Good results for Respiratorius in PK study

Positive results from Respiratorius’ PK study

Summit watch all presentations and interviews

BioStock Life Science Fall Summit 2022

Arcede wants to enter the market for respiratory drugs

Arcede wants to renew the market for respiratory drugs

Respiratoriushas dosed all patients

Last patient dosed in Respiratorius’ PK study with VAL001

Mia Lundblad, CEO Arcede Pharma

Arcede Pharma’s CEO is ready for Spotlight

BioStock Life Science Spring Summit

Watch day 2 of the BioStock Life Science Spring Summit

The BioStock Life Science Spring Summit starts now

new preclinical results for Respiratorius

New results open up for a broader indication for Respiratorius

Respiratorius to split into two companies

Focus on company split for Respiratorius during Q4

BioStock life science spring summit 2022

BioStock Life Science Spring Summit, June 8-9, 2022

BIoStock Investor Meeting 16 mars

BioStock Investor Meeting 16 March

Respiratorius

Strong start to 2022 for Respiratorius

Respiratorius to carry out rights issue

Respiratorius raises 45 MSEK and prepares COPD project spinoff

BioStock investor meeting March 16

BioStock Investor Meeting, March 16

Respiratorius

Respiratorius gets green light for PK study

Several important steps for Respiratorius this fall

Respiratorius has taken several steps this autumn

BioStock Life Science Summit 20 – 21 Oktober 2021

Join us for the BioStock Life Science Summit on October 20...

Respiratorius begins production of VAL001

Respiratorius begins production of VAL001

Respiratorius’ RCD405 shows efficacy in preclinical study

Respiratorius’ RCD405 shows efficacy in preclinical study

Respiratorius has received patent approval in Brazil1 i Brasilien

Respiratorius gets patent approval in Brazil for VAL001

Iconovo looks to the US where it now meets quality requirements

Patent approval stamp

Patent approved for Respiratorius’ COPD project

High expectations on a deal for Respiratorius

Respiratorius turns its focus to COPD and severe asthma

Eventful stock market journey for Respiratorius in Q3

Respiratorius recruits project manager

Respiratorius’ CEO looks forward to a new eventful year

Immunicum finalises phase I ILIAD trial

Respiratorius recruits experienced Clinical Director

Respiratorius carries out directed share issue and initiates bridging study with...

Respiratorius sees great potential for new COPD treatment

Respiratorius looks forward to exciting autumn

Innovation in focus at BioStock Life Science Spring Summit 2021

Respiratorius and Iconovo collaborate on inhalation product for COPD

© BioStock 2023